Search bioRxiv⌕ Search

Biology subjects

Gaiser, J.

Publications and source records attributed to Gaiser, J..

2 recordsLinked to original sources

Simpatico: accurate and ultra-fast virtual drug screening with atomic embeddings

Virtual screening, the in-silico assessment of large libraries of small molecules for binding to a therapeutic protein target, is a critical early step in drug discovery. The dominant approach, molecular docking, requires a separate calculation for each protein-molecule pair, and is too slow to apply alone at the billion-compound scale of modern compound libraries. A recent embedding-retrieval paradigm, exemplified by DrugCLIP, addresses this bottleneck by training deep models to map proteins and small molecules into a shared embedding space, such that proteins are co-located with their likely binding partners; candidate ligands can then be retrieved directly by nearest-neighbors search, with no per-pair calculation. However, current embedding-retrieval methods collapse each protein and each ligand into a single embedding, creating an information bottleneck that limits the representation of partial or alternative binding compatibility. We present simpatico, an embedding-retrieval virtual screening tool that instead produces a unique embedding for each atom in a protein pocket or ligand. A CLIP-style contrastive objective trains these atomic embeddings so that protein-ligand atom pairs known to interact are nearby in embedding space. To screen a protein target, each protein-atom embedding is used as a query against a vector database of precomputed small-molecule atomic embeddings, returning the closest atoms in the library; a simple aggregation step assigns a binding score to each candidate molecule containing retrieved atoms. Where prior retrieval-based methods index one vector per ligand, simpatico indexes one per heavy atom; query time grows sublinearly in library size. On challenging decoy benchmarks, simpatico achieves state-of-the-art predictive accuracy, outperforming recent dense-retrieval methods despite training on only [~]15,000 protein-ligand complexes from PDBBind, with no pretraining and no 3D ligand pose estimation. Simpatico also exceeds the accuracy of physics-based docking and deep-learning-augmented docking methods, is competitive with diffusion-based docking, and runs orders of magnitude faster than all three. Simpatico is open source software; all code, weights, and data may be accessed at https://github.com/TravisWheelerLab/Simpatico.

pharmacology and toxicology↗

Molecular fingerprints are not useful in large-scale search for similarly active compounds

Computational approaches for small-molecule drug discovery now regularly scale to consideration of libraries containing billions of candidate small molecules. One promising approach to increased speed in evaluating billion-molecule libraries is to develop succinct representations of each molecule that enable rapid identification of molecules with similar properties. Molecular fingerprints are thought to provide a mechanism for producing such representations. Here, we explore the utility of commonly-used fingerprints in the context of predicting similar molecular activity. We show that fingerprint similarity provides little discriminative power between active and inactive molecules for a target protein based on a known active - while they may sometimes provide some enrichment for active molecules in a drug screen, a screened dataset will still be dominated by inactive molecules. We also demonstrate that high-similarity actives appear to share a scaffold with the query active, meaning that they could more easily be identified by structural enumeration. Furthermore, even when limited to only active molecules, fingerprint similarity values do not correlate with compound potency. In sum, these results highlight the need for a new wave of molecular representations that will improve the capacity to detect biologically active molecules based on similarity to other such molecules.

pharmacology and toxicology↗